LFG
AMPH icon

Larson Financial Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Larson Financial Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404 Hold
20
– – ﹤0.01% 3523
2026
Q1 		$392 Sell
20
-748
-97% -$18.3K ﹤0.01% 3357
2025
Q4 		$20.6K Buy
768
+359
+88% +$9.25K ﹤0.01% 1707
2025
Q3 		$10.9K Buy
409
+381
+1,361% +$9.84K ﹤0.01% 1973
2025
Q2 		$643 Sell
28
-597
-96% -$14.8K ﹤0.01% 2786
2025
Q1 		$18.1K Buy
+625
New +$20K ﹤0.01% 1404

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Larson Financial Group's AMPH Position: Q2 2026 in Review

Larson Financial Group held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 20 shares worth $404. The position accounts for ﹤0.01% of the portfolio, ranked #3523.

Larson Financial Group first reported a position in AMPH in Q1 2025 and has held it in 6 quarters since. The position peaked at $20.6K in Q4 2025. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Larson Financial Group held 20 shares of Amphastar Pharmaceuticals worth $404 as of Q2 2026.
  • Larson Financial Group left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3523 holding.
  • Larson Financial Group first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Amphastar Pharmaceuticals position peaked at $20.6K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.